Predicting neoadjuvant treatment response in triple-negative breast cancer using machine learning
S. Bhattarai, G. Saini, H. Li, H. Duanmu, G. Seth, T. B. Fisher, E. A. M. Janssen, U. Kiraz, J. Kong, R. Aneja
This study uses machine learning to predict neoadjuvant chemotherapy response in triple-negative breast cancer by combining histological and molecular biomarkers.
bioRxiv · Apr 17, 2023 · PreprintCancer Biology